204 related articles for article (PubMed ID: 19324884)
1. Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity.
Satpathy M; Shao M; Emerson R; Donner DB; Matei D
J Biol Chem; 2009 Jun; 284(23):15390-9. PubMed ID: 19324884
[TBL] [Abstract][Full Text] [Related]
2. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Melnikova VO; Mourad-Zeidan AA; Lev DC; Bar-Eli M
J Biol Chem; 2006 Feb; 281(5):2911-22. PubMed ID: 16306050
[TBL] [Abstract][Full Text] [Related]
3. Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B; Chelladurai B; Schmitt J; Emerson R; Turchi JJ; Matei D
Neoplasia; 2013 Jun; 15(6):609-19. PubMed ID: 23730209
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
Shao M; Cao L; Shen C; Satpathy M; Chelladurai B; Bigsby RM; Nakshatri H; Matei D
Cancer Res; 2009 Dec; 69(24):9192-201. PubMed ID: 19951993
[TBL] [Abstract][Full Text] [Related]
5. Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase.
Satpathy M; Cao L; Pincheira R; Emerson R; Bigsby R; Nakshatri H; Matei D
Cancer Res; 2007 Aug; 67(15):7194-202. PubMed ID: 17671187
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of fibronectin and tissue transglutaminase promotes cell invasion involving increased association with integrin and MMP expression in A431 cells.
Chen SH; Lin CY; Lee LT; Chang GD; Lee PP; Hung CC; Kao WT; Tsai PH; Schally AV; Hwang JJ; Lee MT
Anticancer Res; 2010 Oct; 30(10):4177-86. PubMed ID: 21036738
[TBL] [Abstract][Full Text] [Related]
7. Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.
Munezane T; Hasegawa T; Suritala ; Tanaka A; Okada K; Okita Y
J Vasc Surg; 2010 Oct; 52(4):967-74. PubMed ID: 20615646
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling.
Cao L; Petrusca DN; Satpathy M; Nakshatri H; Petrache I; Matei D
Carcinogenesis; 2008 Oct; 29(10):1893-900. PubMed ID: 18667446
[TBL] [Abstract][Full Text] [Related]
9. Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism.
Condello S; Cao L; Matei D
FASEB J; 2013 Aug; 27(8):3100-12. PubMed ID: 23640056
[TBL] [Abstract][Full Text] [Related]
10. Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.
Xie Y; Nakanishi T; Natarajan K; Safren L; Hamburger AW; Hussain A; Ross DD
Biochim Biophys Acta; 2015 Mar; 1849(3):317-27. PubMed ID: 25615818
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells.
Stearns ME; Kim G; Garcia F; Wang M
Mol Cancer Res; 2004 Jul; 2(7):403-16. PubMed ID: 15280448
[TBL] [Abstract][Full Text] [Related]
12. Activated matrix metalloproteinase-2--a potential marker of prognosis for epithelial ovarian cancer.
Wu X; Li H; Kang L; Li L; Wang W; Shan B
Gynecol Oncol; 2002 Jan; 84(1):126-34. PubMed ID: 11748988
[TBL] [Abstract][Full Text] [Related]
13. Transglutaminase type 2 in human abdominal aortic aneurysm is a potential factor in the stabilization of extracellular matrix.
Shin S; Cho YP; Jun H; Park H; Hong HN; Kwon TW
J Vasc Surg; 2013 May; 57(5):1362-70. PubMed ID: 23538006
[TBL] [Abstract][Full Text] [Related]
14. Tissue transglutaminase-induced alterations in extracellular matrix inhibit tumor invasion.
Mangala LS; Arun B; Sahin AA; Mehta K
Mol Cancer; 2005 Sep; 4():33. PubMed ID: 16153302
[TBL] [Abstract][Full Text] [Related]
15. Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer.
Cao L; Shao M; Schilder J; Guise T; Mohammad KS; Matei D
Oncogene; 2012 May; 31(20):2521-34. PubMed ID: 21963846
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
Cheung LW; Leung PC; Wong AS
Cancer Res; 2006 Nov; 66(22):10902-10. PubMed ID: 17108127
[TBL] [Abstract][Full Text] [Related]
17. cAMP response element-binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation.
Linnerth NM; Greenaway JB; Petrik JJ; Moorehead RA
Int J Gynecol Cancer; 2008; 18(6):1248-57. PubMed ID: 18554190
[TBL] [Abstract][Full Text] [Related]
18. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
[TBL] [Abstract][Full Text] [Related]
19. The reinforcement of invasion in epithelial ovarian cancer cells by 17 beta-Estradiol is associated with up-regulation of Snail.
Ding JX; Feng YJ; Yao LQ; Yu M; Jin HY; Yin LH
Gynecol Oncol; 2006 Nov; 103(2):623-30. PubMed ID: 16806441
[TBL] [Abstract][Full Text] [Related]
20. Role of tissue transglutaminase 2 in the acquisition of a mesenchymal-like phenotype in highly invasive A431 tumor cells.
Lin CY; Tsai PH; Kandaswami CC; Chang GD; Cheng CH; Huang CJ; Lee PP; Hwang JJ; Lee MT
Mol Cancer; 2011 Jul; 10():87. PubMed ID: 21777419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
